64x Bio is transforming cell and gene therapy through high throughput engineering of mammalian cell lines, enabling pharmaceutical and biotechnology companies to manufacture next-generation therapeutics more effectively. Their innovative platform combines genome engineering and computational tools to create optimized cell lines that address critical bottlenecks in gene therapy production, positioning them as a key player in the biotech industry.

ALICE Technologies is the developer of an AI-powered construction simulation platform. It leverages artificial intelligence to analyze a project's complex building requirements,  generate efficient building schedules, and tune those schedules as needed during construction. The company's platform enables contractors and owners to plan, bid, and build more effectively, reducing construction times and labor costs by $30 million for a typical $500 million construction project. ALICE Technologies works with construction leaders in the infrastructure and commercial construction segments, such as Parsons, HDCC, and Kajima Corporation.

atai Life Sciences is a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders. With a robust pipeline of innovative treatments, the company aims to address significant unmet medical needs in the mental health space. Leveraging proprietary technology and a dedicated team, atai is committed to accelerating drug development and improving patient outcomes. The company operates in major markets, including the U.S. and Europe, and is positioned to lead in the mental health treatment sector, addressing the needs of millions affected by mental health disorders.

Beeflow is a biotechnology company that provides professional pollination services to farmers, enhancing crop yield potential and fruit quality through a platform of proprietary technologies. The company stands out for its comprehensive understanding of both plant science and bee biology, managing pollination using scientific knowledge and crop data. Founded in 2016, Beeflow has expanded operations internationally, including in Latin America, to meet the growing demand for blueberry pollination services. Their innovative approach ensures efficient pollination, leading to consistent fruit quality and higher yields, positioning them as a leader in the agricultural biotechnology sector.

Cambrian Biopharma is a clinical-stage drug development company focused on creating transformative therapies to treat and prevent chronic diseases associated with aging. By partnering with leading scientists, Cambrian aims to develop a new class of medicines that extend healthspan, the period of life spent in good health. Their innovative approach combines scientific rigor with a commitment to making therapies widely available, leveraging a distributed development model to efficiently advance multiple programs simultaneously. With a strong emphasis on preventive medicine, Cambrian is positioned to redefine healthcare in the 21st century, targeting the mechanistic drivers of aging and aiming to improve the quality of life for individuals worldwide.

Commonwealth Fusion Systems (CFS) is the world's largest and leading commercial fusion energy company, utilizing revolutionary high-temperature superconducting magnets to build smaller, cost-effective tokamak fusion systems. Founded in 2018 as a spin-off from MIT, CFS aims to deliver clean, abundant fusion energy through its flagship project, SPARC, which will pave the way for the first fusion power plant, ARC. With over $2 billion raised, CFS is positioned at the forefront of the fusion energy market, combining decades of research with innovative technology to combat climate change and provide a sustainable energy source.

Copernic Catalysts designs innovative catalysts for zero-carbon chemicals and e-fuels, focusing on cost-effective and scalable solutions. Their technology enhances the design of heterogeneous catalysts, crucial for the chemical industry, by utilizing advanced scientific computing tools. With a commitment to sustainability, Copernic aims to transform the chemical industry by providing economically viable solutions that align with existing infrastructure, thereby accelerating the development of catalysts for a sustainable future.

Deep Genomics is an AI-driven genetic medicine company that focuses on programming RNA therapies for any gene and genetic condition. Their proprietary AI platform, Big RNA, enables the discovery of novel therapeutic candidates by untangling the complexities of RNA biology. With a strong interdisciplinary team of over 100 experts, they have made significant advancements in RNA therapeutic development, including the release of the first Foundation Model for RNA Biology. The company is positioned at the forefront of drug development, leveraging AI to address complex genetic diseases and has received recognition as a leading biotechnology company.

Earthshot Labs is a platform focused on developing and financing nature-based carbon projects, integrating scientific rigor into carbon markets. The company supports land stewards by providing verified carbon credits and financing for restoration and conservation projects. Their offerings include pre-feasibility studies, project design, and strategic carbon accounting advisory. Earthshot Labs aims to make nature an investable asset class, enhancing deal flow efficiency through advanced ecosystem analytics. Their mission is to scale reforestation and conservation efforts globally, addressing ecological and climate crises while ensuring equitable benefits for local communities.

Faeth Therapeutics is pioneering a new treatment paradigm for cancer by utilizing metabolism and precision nutrition. The company employs a systematic approach that combines computational biology and AI to understand the metabolic processes fueling cancer cell growth. Unlike traditional therapies that target single pathways, Faeth's multi-nodal treatment approach aims to fully inhibit cancer cell growth by improving and expanding available drug targets. With a data-driven and evidence-based methodology, Faeth is currently conducting multiple clinical trials, leveraging a discovery platform that matches tumor genotypes with tailored treatment regimens and precision diets to enhance patient outcomes. The company is positioned at the forefront of cancer treatment innovation, backed by leading investors and a team of world-class scientists.

Gameto is a female-led biotech company focused on developing innovative treatment solutions to enhance women's reproductive health across their lifespan. The company addresses significant gaps in the fertility space, particularly in IVF and egg freezing, by leveraging advanced cellular engineering techniques. Their flagship product, Fertilo, aims to modernize and improve the IVF process, making it safer and more effective. Gameto's platform has the potential to revolutionize women's health by providing better therapeutic options for conditions related to infertility, menopause, and other reproductive health issues. With a strong commitment to scientific advancement and a mission-driven team, Gameto is positioned to make a substantial impact in the underdeveloped area of women's health.

Glass Imaging Inc. leverages artificial intelligence to enhance smartphone camera performance, delivering DSLR-quality images through innovative software and hardware solutions. Their flagship product, a custom neural ISP, boosts camera performance by up to 10x and is designed for current and future smartphones. The company differentiates itself by reversing lens aberrations and sensor imperfections, positioning itself as a leader in the smartphone imaging market. With a venture-backed model, Glass Imaging is poised for significant growth as it transforms smartphone photography.